Company intelligence
MLex
Global newswire covering Antitrust, M&A, Trade, Data Privacy, Tech & AI, Energy, Financial Crime & Financial Services
About MLex
An independent news organization with a global reach, MLex is focused on identifying regulatory risk as and wherever it emerges, empowering our customers — the world’s leading law firms, corporations, hedge funds, advisory firms and regulators — to navigate threats and opportunities in a world where regulation is increasingly complex and interconnected. We have a track record of uncovering regulatory risk before it breaks in other news outlets, with specialist reporting across Antitrust, M&A, State Aid, Trade, Data Privacy & Security, Technology, Artificial Intelligence, Intellectual Property, Energy, Financial Services and Financial Crime.
Verified activity
Signals from MLex
4 published signals
Research & Knowledge
MLex Senior M&A Reporter Curtis Eichelberger shares investigations on US national security screening of major M&A deals, including CFIUS on-site mitigation inspections, foreign investment regulators, and CFIUS focus on merger target vulnerabilities.
Reported by MLex
Research & Knowledge
MLex published the MLex Europe newsletter written by Todd Buell, MLex Deputy Managing Editor, Brussels, covering key developments from across Europe on AI, antitrust, technology, and other MLex coverage areas.
Reported by MLex
Legal & Regulatory
MLex received a short-term renewal of the USPTO fee-setting authority, which was included in a federal budget continuing resolution passed by the House last night.
Reported by Nick Robertson
Legal & Regulatory
MLex published a blog post analyzing the DC Circuit decision regarding the FDA Hatch-Waxman exclusivity forfeiture law and tentative FDA approval.
Reported by Nick Robertson